Results 11 to 20 of about 2,533,606 (305)
Sports soft tissue injury [PDF]
This was a powerpoint presentation to the Nurse Practitioner conference in June 2008. The aim was to give a overview of the most up to date evidence on the way soft tissue is damaged, the process of healing and from this aim at a way for best ...
Harmsworth, Mark
core +9 more sources
Ifosfamide with regional hyperthermia in soft-tissue sarcomas [PDF]
, 2003 For high-risk soft tissue sarcomas (HR-STS) of adults, new treatment strategies are needed to improve outcome with regard to local control and overall survival.
M. Schlemmer +5 more
core +1 more source
Late-onset meningeal metastases in liposarcoma: A case report and review of the literature [PDF]
, 2006 Intracranial metastases from liposarcoma are rare and almost always preceded by the development of systemic tumour spread. We report here a case of liposarcoma with spread to the cranial nervous system 23 years after treatment of the primary tumour.
White, J. +3 more
core +1 more source
Hepatology, EarlyView., 2022 Phase 1b study of anlotinib combined with TQB2450 in pretreated advanced biliary tract cancer and biomarker analysis. Abstract Background and Aims We evaluated the efficacy and safety of the antiangiogenic tyrosine kinase inhibitor anlotinib plus TQB2450, a programmed death‐ligand 1 inhibitor in pretreated advanced biliary tract cancers (BTCs ...
Jun Zhou +13 more
wiley +1 more source
Efficacy of consolidation high-dose chemotherapy with ifosfamide, carboplatin and etoposide (HD-ICE) followed by autologous peripheral blood stem cell rescue in chemosensitive patients with metastatic soft tissue sarcomas [PDF]
, 2006 Background: Prognosis of patients with metastatic soft tissue sarcomas (MSTS) is poor even after response to doxorubicin-based chemotherapy. We report phase II data of highdose chemotherapy and peripheral blood stem cell (PBSC) rescue in patients with ...
Hentrich, M. +33 more
core +1 more source
Updates in Pathology for Retroperitoneal Soft Tissue Sarcoma
, 2022 Retroperitoneal tumors are extremely rare. More than 70% of primary retroperitoneal soft tissue tumors are malignant. The most common sarcomas in the retroperitoneum include liposarcomas and leiomyosarcoma, however other sarcomas, along with benign ...
Purgina, Bibianna +3 more
core +1 more source
Immunotherapy in Soft-Tissue Sarcoma [PDF]
Current Oncology, 2020 Soft-tissue sarcoma (sts) is a rare mesenchymal malignancy that accounts for less than 1% of all adult tumours. Despite the successful advancement of localized therapies such as surgery and radiotherapy, these tumours can, for many, recur—often with metastatic disease.
O, Ayodele, A R Abdul, Razak
openaire +2 more sources
PI3K inhibition enhances doxorubicin-induced apoptosis in sarcoma cells [PDF]
, 2012 We searched for a drug capable of sensitization of sarcoma cells to doxorubicin (DOX). We report that the dual PI3K/mTOR inhibitor PI103 enhances the efficacy of DOX in several sarcoma cell lines and interacts with DOX in the induction of apoptosis ...
Dittmann, Kai +37 more
core +1 more source
BMC Musculoskeletal Disorders, 2021 Background Like with all cancers, multidisciplinary team (MDT) meetings are the norm in bone and soft tissue tumour (BST) management too. Problem in attendance of specialists due to geographical location is the one of the key barriers to effective ...
Raja Bhaskara Rajasekaran +4 more
doaj +1 more source